Hong Kong Undervalued Stocks Based On Cash Flows

Jiangxi Rimag Group

Market Cap: HK$5.0b

Invests and operates medical imaging centers in China.

Shanghai Conant Optical

Market Cap: HK$17.9b

Manufactures and sells resin spectacle lenses in Mainland China, the Americas, Asia, Europe, Oceania, and Africa.

Wanguo Gold Group

Market Cap: HK$34.0b

An investment holding company, engages in mining, ore processing, and sale of concentrate products in the People’s Republic of China and Solomon Islands.

Giant Biogene Holding

Market Cap: HK$61.1b

An investment holding company, designs, develops, manufactures, and sells skin treatment products with recombinant collagen in the People’s Republic of China.

Everest Medicines

Market Cap: HK$20.2b

A biopharmaceutical company, engages in the discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets.

ASMPT

Market Cap: HK$24.0b

An investment holding company, engages in the design, manufacture, and marketing of machines, tools, and materials used in the semiconductor and electronics assembly industries internationally.

Intron Technology Holdings

Market Cap: HK$1.6b

An investment holding company, operates as an automotive electronics solutions provider in Hong Kong, the Mainland China, and internationally.

Simcere Pharmaceutical Group

Market Cap: HK$27.5b

An investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products to distributors, pharmacy chains, and other pharmaceutical manufacturers in China.

RemeGen

Market Cap: HK$37.5b

A biopharmaceutical company, engages in the discovery, development, and commercialization of biologics for the treatment of autoimmune, oncology, and ophthalmic diseases with unmet medical needs in Mainland China and the United States.

Sichuan Kelun-Biotech Biopharmaceutical

Market Cap: HK$74.8b

A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, and other therapeutic areas in the People’s Republic of China and internationally.

BYD

Market Cap: HK$1.1t

Engages in automobiles and batteries business in the People’s Republic of China, Hong Kong, Macau, Taiwan, and internationally.

Beijing Chunlizhengda Medical Instruments

Market Cap: HK$7.0b

Beijing Chunlizhengda Medical Instruments Co., Ltd.

Akeso

Market Cap: HK$82.5b

A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.

Bosideng International Holdings

Market Cap: HK$53.2b

Engages in the apparel business in the People’s Republic of China.

Beijing Fourth Paradigm Technology

Market Cap: HK$25.4b

An investment holding company, provides platform-centric artificial intelligence (AI) solutions in the People's Republic of China.

Innovent Biologics

Market Cap: HK$129.5b

A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, and internationally.

Hua Hong Semiconductor

Market Cap: HK$70.1b

An investment holding company, engages in the manufacture and sale of semiconductor products in China, North America, Asia, Europe, and Japan.

WEILONG Delicious Global Holdings

Market Cap: HK$35.3b

Produces and sells spicy snack food in the People’s Republic of China and internationally.

Lingbao Gold Group

Market Cap: HK$13.2b

Primarily engages in mining, processing, smelting, refining, and sale of gold products in the People’s Republic of China.

Genscript Biotech

Market Cap: HK$32.2b

An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.

Acotec Scientific Holdings

Market Cap: HK$2.8b

Operates as an interventional medical device company that offers vascular interventional treatment products in Mainland China and internationally.

Plover Bay Technologies

Market Cap: HK$6.4b

An investment holding company, designs, develops, and markets software defined wide area network routers.

Nongfu Spring

Market Cap: HK$451.0b

Produces and sells packaged drinking water and beverage products primarily in Mainland China.

Bairong

Market Cap: HK$4.1b

An investment holding company, operates as an artificial intelligence (AI) technology services company in China.

Chinasoft International

Market Cap: HK$12.4b

Engages in development and provision of information technology (IT) solutions, IT outsourcing, and training services in the People’s Republic of China, the United States, Malaysia, Japan, Singapore, India, and Saudi Arabia.

Essex Bio-Technology

Market Cap: HK$2.5b

An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.

MicroPort NeuroScientific

Market Cap: HK$7.5b

Provides neuro-interventional medical devices.

Shanghai MicroPort MedBot (Group)

Market Cap: HK$16.6b

Shanghai MicroPort MedBot (Group) Co., Ltd.

CSC Financial

Market Cap: HK$183.5b

Provides investment banking services in Mainland China and internationally.

DPC Dash

Market Cap: HK$13.4b

Operates a chain of fast-food restaurants in the People’s Republic of China.

Zhaojin Mining Industry

Market Cap: HK$72.3b

An investment holding company, engages in exploration, mining, processing, smelting, and sale of gold and other metallic products in the People’s Republic of China and internationally.

Viva Biotech Holdings

Market Cap: HK$3.2b

An investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide.